{"id":"W2129453496","doi":"10.1530/eje-13-0825","title":"Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network","year":2014,"lang":"en","type":"article","venue":"European Journal of Endocrinology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Sorafenib; Sunitinib; Vandetanib; Internal medicine; Oncology; Thyroid carcinoma; Thyroid cancer; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Tyrosine-kinase inhibitor; Thyroid; Clinical trial; Gastroenterology; Cancer; Phases of clinical research; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002146416,0.0002011471,0.0006026999,0.0001344288,0.00005163337,0.000007192822,0.0001617788,0.0000102916,0.00001566768],"category_scores_gemma":[0.00008219039,0.0001078741,0.0001091751,0.0002690764,0.00009983395,0.00005397627,0.00007395221,0.0002655392,0.000004452298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001966633,"about_ca_system_score_gemma":0.00004950493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003558338,"about_ca_topic_score_gemma":0.00004941866,"domain_scores_codex":[0.9978792,0.0007056614,0.0005896402,0.0002051693,0.000315424,0.0003049273],"domain_scores_gemma":[0.99872,0.00005510223,0.0005625761,0.0003543479,0.0002153801,0.00009254694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001180078,0.003431841,0.991834,0.000009505905,0.0004849567,0.0004706001,0.000634792,0.0001597635,0.00005896185,0.00007282916,0.0003075088,0.001355161],"study_design_scores_gemma":[0.02352441,0.02305584,0.9518731,0.0001506748,0.0005391709,0.00008060514,0.0002148248,0.000001908143,0.0002694884,0.00002046668,0.0001919022,0.00007766014],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975473,0.0006542865,0.00001123677,0.0002073886,0.0002572727,0.0005350274,0.000004952472,0.00000593435,0.0007765613],"genre_scores_gemma":[0.9993627,0.00003735934,0.0002470996,0.00009824924,0.0001647567,0.000006980822,0.000001973281,0.00003268382,0.00004820533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03996095,"threshold_uncertainty_score":0.4398976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01135633399203673,"score_gpt":0.2321794376689841,"score_spread":0.2208231036769473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}